No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs542866795 |
chr5:49735076-49735077 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs188798031 |
chr5:49735086-49735087 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs55639144 |
chr5:49735109-49735110 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs553132326 |
chr5:49735156-49735157 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs532101989 |
chr5:49735245-49735246 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs544816943 |
chr5:49735269-49735270 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs374281936 |
chr5:49735296-49735297 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs373067302 |
chr5:49735322-49735323 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs397884028 |
chr5:49735323-49735324 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs144295147 |
chr5:49735339-49735340 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs60745446 |
chr5:49735340-49735341 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs564223565 |
chr5:49735346-49735347 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs533276664 |
chr5:49735354-49735355 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs28661824 |
chr5:49735370-49735371 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
15 |
rs192638677 |
chr5:49735475-49735476 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs28445612 |
chr5:49735510-49735511 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
17 |
rs184131431 |
chr5:49735542-49735543 |
Weak transcription Active TSS Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs115874329 |
chr5:49735729-49735730 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs549609518 |
chr5:49735767-49735768 |
Enhancers Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs188579826 |
chr5:49735807-49735808 |
Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs535185111 |
chr5:49735809-49735810 |
Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs558424930 |
chr5:49735842-49735843 |
Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs116590738 |
chr5:49735844-49735845 |
Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs180677843 |
chr5:49735863-49735864 |
Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs528674368 |
chr5:49735877-49735878 |
Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs557101638 |
chr5:49735907-49735908 |
Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs573532760 |
chr5:49735920-49735921 |
Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs201108935 |
chr5:49735948-49735949 |
Flanking Active TSS Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs542280164 |
chr5:49736011-49736012 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs114399247 |
chr5:49736019-49736020 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs374478011 |
chr5:49736042-49736043 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs183689769 |
chr5:49736085-49736086 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs148674387 |
chr5:49736092-49736093 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs189183215 |
chr5:49736119-49736120 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs142157413 |
chr5:49736140-49736141 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs564782399 |
chr5:49736142-49736143 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs533244673 |
chr5:49736144-49736145 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs543472998 |
chr5:49736153-49736154 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs563635758 |
chr5:49736166-49736167 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs61657013 |
chr5:49736171-49736172 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs549124706 |
chr5:49736244-49736245 |
Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs566348724 |
chr5:49736281-49736282 |
Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs528822867 |
chr5:49736304-49736305 |
Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs182518405 |
chr5:49736316-49736317 |
Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs147910527 |
chr5:49736323-49736324 |
Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs71612354 |
chr5:49736368-49736369 |
Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs70972912 |
chr5:49736388-49736389 |
Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs186648340 |
chr5:49736442-49736443 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs550621593 |
chr5:49736443-49736444 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs567262583 |
chr5:49736456-49736457 |
Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|